1. Home
  2. RVMD vs MLM Comparison

RVMD vs MLM Comparison

Compare RVMD & MLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

SELL

Current Price

$193.42

Market Cap

40.3B

Sector

Health Care

ML Signal

SELL

Logo Martin Marietta Materials Inc.

MLM

Martin Marietta Materials Inc.

SELL

Current Price

$470.96

Market Cap

34.4B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
RVMD
MLM
Founded
2014
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
40.3B
34.4B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
RVMD
MLM
Price
$193.42
$470.96
Analyst Decision
Strong Buy
Buy
Analyst Count
24
24
Target Price
$259.14
★ $633.92
AVG Volume (30 Days)
★ 2.2M
728.5K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
★ 0.71%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 29.27
Revenue
N/A
★ $6,150,000,000.00
Revenue This Year
N/A
$27.17
Revenue Next Year
$564.95
$23.04
P/E Ratio
★ N/A
$16.14
Revenue Growth
★ N/A
N/A
52 Week Low
$49.05
$470.19
52 Week High
$224.31
$710.97

Technical Indicators

Market Signals
Indicator
RVMD
MLM
Relative Strength Index (RSI) 44.06 34.56
Support Level $188.18 $470.19
Resistance Level $194.19 $636.33
Average True Range (ATR) 8.63 10.75
MACD -1.27 0.42
Stochastic Oscillator 41.68 19.64

Price Performance

Historical Comparison
RVMD
MLM

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About MLM Martin Marietta Materials Inc.

Martin Marietta is a leading US producer of construction aggregates, having produced roughly 200 million tons in 2025. Its aggregate reserves represent approximately 85 years of supply at 2025 production levels. Over the past several years, the company has increased its exposure to aggregates while reducing its presence in cement and downstream businesses such as concrete and asphalt. More recently, Martin Marietta expanded into an aggregate-adjacent business through its acquisition of Lhoist North America, the largest US producer of lime. The company operates across 28 states, with smaller operations in Canada and the Bahamas.

Share on Social Networks: